STOCK TITAN

Zumiez Financials

ZUMZ
FY2025 annual
Revenue $929.1M +4.5% YoY
Net Income $13.4M +888.2% YoY
EPS (Diluted) $0.78 +966.7% YoY
Free Cash Flow $42.4M +644.5% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2027, ended May 2, 2026 Reported Currency USD FYE January

Zumiez (ZUMZ) reported $929.1M in revenue for fiscal year 2025, up 4.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ZUMZ FY2025

Zumiez’s recovery is currently a margin-and-cash-conversion story, but inventory and leverage keep the balance sheet less flexible.

Operating cash flow in FY2025 was $53.5M, roughly four times net income of $13.4M, so reported profit understated cash generation. After capital expenditures of $11.1M, free cash flow was $42.4M, indicating the cash surplus was not consumed by reinvestment.

The gross margin recovered to 35.8% in FY2025 from 32.1% in FY2023, indicating merchandise economics improved after the trough. Operating margin rose from -7.4% to 1.8% over the same span, but only a small portion of gross profit reaches operations.

Cash rose to $127.9M while inventory stayed near $147.0M, making inventory the dominant cash commitment and limiting how liquid the balance sheet really is. Debt-to-equity rose to 1.0x from 0.8x between FY2021 and FY2025, showing greater balance-sheet leverage.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 40 / 100
Financial Health Score 40/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Zumiez's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
30

Zumiez has an operating margin of 1.8%, meaning the company retains $2 of operating profit per $100 of revenue. This results in a moderate score of 30/100, indicating healthy but not exceptional operating efficiency. This is up from 0.2% the prior year.

Growth
42

Zumiez's revenue grew a modest 4.5% year-over-year to $929.1M. This slow but positive growth earns a score of 42/100.

Leverage
46

Zumiez has a moderate D/E ratio of 0.99. This balance of debt and equity financing earns a leverage score of 46/100.

Liquidity
58

Zumiez's current ratio of 2.01 indicates adequate short-term liquidity, earning a score of 58/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
37

Zumiez has a free cash flow margin of 4.6%, earning a moderate score of 37/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
28

Zumiez generates a 4.1% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 28/100. This is up from -0.5% the prior year.

Altman Z-Score Grey Zone
2.70

Zumiez scores 2.70, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
7/8

Zumiez passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
3.99x

For every $1 of reported earnings, Zumiez generates $3.99 in operating cash flow ($53.5M OCF vs $13.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$929.1M
YoY+4.5%
5Y CAGR-1.3%
10Y CAGR+1.5%

Zumiez generated $929.1M in revenue in fiscal year 2025. This represents an increase of 4.5% from the prior year.

EBITDA
$38.2M
YoY+58.3%
5Y CAGR-20.6%
10Y CAGR-6.7%

Zumiez's EBITDA was $38.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 58.3% from the prior year.

Net Income
$13.4M
YoY+888.2%
5Y CAGR-29.4%
10Y CAGR-7.4%

Zumiez reported $13.4M in net income in fiscal year 2025. This represents an increase of 888.2% from the prior year.

EPS (Diluted)
$0.78
YoY+966.7%
5Y CAGR-23.6%
10Y CAGR-2.8%

Zumiez earned $0.78 per diluted share (EPS) in fiscal year 2025. This represents an increase of 966.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$42.4M
YoY+644.5%
5Y CAGR-20.0%
10Y CAGR+11.3%

Zumiez generated $42.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 644.5% from the prior year.

Cash & Debt
$127.9M
YoY+13.5%
5Y CAGR+11.7%
10Y CAGR+11.5%

Zumiez held $127.9M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
17M
YoY-11.4%
5Y CAGR-7.9%
10Y CAGR-4.0%

Zumiez had 17M shares outstanding in fiscal year 2025. This represents a decrease of 11.4% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
35.8%
YoY+1.7pp
5Y CAGR+0.5pp
10Y CAGR+2.4pp

Zumiez's gross margin was 35.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.7 percentage points from the prior year.

Operating Margin
1.8%
YoY+1.6pp
5Y CAGR-8.0pp
10Y CAGR-3.9pp

Zumiez's operating margin was 1.8% in fiscal year 2025, reflecting core business profitability. This is up 1.6 percentage points from the prior year.

Net Margin
1.4%
YoY+1.6pp
5Y CAGR-6.3pp
10Y CAGR-2.1pp

Zumiez's net profit margin was 1.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.6 percentage points from the prior year.

Return on Equity
4.1%
YoY+4.7pp
5Y CAGR-9.7pp
10Y CAGR-5.6pp

Zumiez's ROE was 4.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 4.7 percentage points from the prior year.

Capital Allocation

Share Buybacks
$38.3M
YoY+51.8%

Zumiez spent $38.3M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 51.8% from the prior year.

Capital Expenditures
$11.1M
YoY-26.3%
5Y CAGR+4.1%
10Y CAGR-10.8%

Zumiez invested $11.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 26.3% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

ZUMZ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ZUMZ quarterly income statement
MetricQ2'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25
Revenue$193.3M-19.1%$239.1M+11.6%$214.3M+16.2%$184.3M-32.3%$272.2M+22.4%$222.5M+5.9%$210.2M+18.5%$177.4M
Cost of Revenue$132.0M-11.6%$149.3M+8.0%$138.3M+7.2%$129.0M-26.1%$174.6M+21.1%$144.2M+4.2%$138.4M+10.3%$125.5M
Gross Profit$61.3M-31.7%$89.8M+18.1%$76.0M+37.4%$55.3M-43.3%$97.6M+24.6%$78.3M+9.1%$71.8M+38.3%$51.9M
SG&A Expenses$76.5M-1.9%$78.0M+2.8%$75.9M+1.0%$75.2M-3.3%$77.8M+2.4%$75.9M+5.2%$72.2M+0.2%$72.1M
Operating Income-$15.2M-229.0%$11.8M+10902.8%$107K+100.5%-$19.9M-200.1%$19.8M+738.1%$2.4M+702.5%-$393K+98.1%-$20.2M
Income Tax-$1.2M-136.8%$3.2M+68.7%$1.9M+232.6%-$1.4M-137.7%$3.8M+90.8%$2.0M+42.9%$1.4M+149.7%-$2.8M
Net Income-$13.3M-244.8%$9.2M+1014.2%-$1.0M+93.0%-$14.3M-216.3%$12.3M+962.8%$1.2M+236.8%-$847K+95.0%-$16.8M
EPS (Diluted)-$0.82-249.1%$0.55+1016.7%-$0.06+92.4%-$0.79-202.6%$0.77+1183.3%$0.06+250.0%-$0.04+95.3%-$0.86

Not reported in any period shown, so not listed: R&D Expenses, Interest Expense.

ZUMZ Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ZUMZ quarterly balance sheet
MetricQ2'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25
Total Assets$618.7M-2.3%$633.1M+1.6%$623.4M+4.1%$599.1M-5.6%$634.9M-1.7%$646.0M-3.5%$669.5M+2.0%$656.6M
Current Assets$306.6M-2.7%$315.0M+4.7%$300.8M+7.0%$281.2M-12.8%$322.4M+1.3%$318.4M-2.6%$326.8M+1.8%$321.0M
Cash & Equivalents$66.9M-16.5%$80.1M+1.7%$78.8M+26.0%$62.5M-44.5%$112.7M+132.1%$48.5M-26.2%$65.8M-12.2%$74.9M
Inventory$153.2M-15.2%$180.7M+14.6%$157.7M+5.2%$149.9M+2.2%$146.6M-21.7%$187.2M+17.9%$158.8M+8.1%$146.8M
Accounts ReceivableN/AN/AN/AN/A$6.3MN/AN/AN/A
Goodwill$15.6M+1.4%$15.4M+0.2%$15.3M0.0%$15.3M+0.5%$15.3M-0.8%$15.4M+0.1%$15.4M-0.2%$15.4M
Total Liabilities$312.9M-6.5%$334.6M+1.1%$331.0M+10.1%$300.6M-1.7%$305.9M-7.0%$328.9M-6.0%$349.7M+9.5%$319.3M
Current Liabilities$157.5M-8.9%$172.8M+1.0%$171.0M+16.4%$146.9M-5.6%$155.5M-8.6%$170.1M-5.9%$180.8M+14.9%$157.3M
Total Equity$305.9M+2.5%$298.5M+2.1%$292.4M-2.0%$298.5M-9.3%$329.0M+3.7%$317.1M-0.8%$319.8M-5.2%$337.3M
Retained Earnings$104.5M+0.1%$104.4M+3.6%$100.7M-8.1%$109.6M-26.5%$149.2M+11.0%$134.4M-3.2%$138.9M-12.8%$159.3M

Not reported in any period shown, so not listed: Long-Term Debt.

ZUMZ Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ZUMZ quarterly cash flow statement
MetricQ2'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25
Operating Cash Flow-$28.1M-629.5%$5.3M-57.8%$12.6M+157.0%-$22.1M-140.4%$54.7M+394.5%-$18.6M-688.5%$3.2M+117.0%-$18.6M
Capital Expenditures$1.7M-23.1%$2.2M-28.4%$3.1M+39.6%$2.2M-55.5%$5.0M+33.3%$3.7M+0.7%$3.7M+46.1%$2.5M
Free Cash Flow-$29.8M-1065.4%$3.1M-67.5%$9.5M+139.0%-$24.3M-148.9%$49.7M+322.7%-$22.3M-3849.4%-$565K+97.3%-$21.1M
Investing Cash Flow-$26.3M-1800.2%$1.5M-80.0%$7.7M+284.0%-$4.2M-139.9%$10.5M+69.8%$6.2M-21.8%$7.9M-1.0%$8.0M
Financing Cash Flow-$6.0M-13.8%-$5.2M+29.9%-$7.5M+70.2%-$25.0M$0+100.0%-$5.2M+73.2%-$19.6M-8688.6%$228K
Share Buybacks$6.0M+7.6%$5.6M-25.4%$7.5M-70.4%$25.2M$0-100.0%$5.6MN/AN/A

Not reported in any period shown, so not listed: Dividends Paid.

ZUMZ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

ZUMZ quarterly financial ratios
MetricQ2'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25
Gross Margin31.7%-5.8pp37.5%+2.1pp35.5%+5.5pp30.0%-5.8pp35.9%+0.7pp35.2%+1.0pp34.2%+4.9pp29.3%
Operating Margin-7.9%-12.8pp4.9%+4.9pp0.1%+10.8pp-10.8%-18.1pp7.3%+6.2pp1.1%+1.3pp-0.2%+11.2pp-11.4%
Net Margin-6.9%-10.7pp3.8%+4.3pp-0.5%+7.3pp-7.8%-12.3pp4.5%+4.0pp0.5%+0.9pp-0.4%+9.1pp-9.5%
Return on Equity-4.3%-7.4pp3.1%+3.4pp-0.3%+4.5pp-4.8%-8.5pp3.7%+3.4pp0.4%+0.6pp-0.3%+4.7pp-5.0%
Return on Assets-2.1%-3.6pp1.5%+1.6pp-0.2%+2.2pp-2.4%-4.3pp1.9%+1.8pp0.2%+0.3pp-0.1%+2.4pp-2.6%
Current Ratio1.95+0.1x1.82+0.1x1.76-0.2x1.91-0.2x2.07+0.2x1.87+0.1x1.81-0.2x2.04
Debt-to-Equity1.02-0.1x1.120.0x1.13+0.1x1.01+0.1x0.93-0.1x1.04-0.1x1.09+0.1x0.95
FCF Margin-15.4%-16.7pp1.3%-3.1pp4.4%+17.6pp-13.2%-31.4pp18.3%+28.3pp-10.0%-9.8pp-0.3%+11.6pp-11.9%

Similar Companies

Frequently Asked Questions

What is Zumiez's annual revenue?

Zumiez (ZUMZ) reported $929.1M in total revenue for fiscal year 2025. This represents a 4.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Zumiez's revenue growing?

Zumiez (ZUMZ) revenue grew by 4.5% year-over-year, from $889.2M to $929.1M in fiscal year 2025.

Is Zumiez profitable?

Yes, Zumiez (ZUMZ) reported a net income of $13.4M in fiscal year 2025, with a net profit margin of 1.4%.

Zumiez (ZUMZ) reported diluted earnings per share of $0.78 for fiscal year 2025. This represents a 966.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Zumiez (ZUMZ) had EBITDA of $38.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Zumiez (ZUMZ) had a gross margin of 35.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Zumiez (ZUMZ) had an operating margin of 1.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Zumiez (ZUMZ) had a net profit margin of 1.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Zumiez (ZUMZ) has a return on equity of 4.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Zumiez (ZUMZ) generated $42.4M in free cash flow during fiscal year 2025. This represents a 644.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Zumiez (ZUMZ) generated $53.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Zumiez (ZUMZ) had $644.2M in total assets as of fiscal year 2025, including both current and long-term assets.

Zumiez (ZUMZ) invested $11.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Zumiez (ZUMZ) spent $38.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Zumiez (ZUMZ) had 17M shares outstanding as of fiscal year 2025.

Zumiez (ZUMZ) had a current ratio of 2.01 as of fiscal year 2025, which is generally considered healthy.

Zumiez (ZUMZ) had a debt-to-equity ratio of 0.99 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Zumiez (ZUMZ) had a return on assets of 2.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Zumiez (ZUMZ) has an Altman Z-Score of 2.70, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Zumiez (ZUMZ) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Zumiez (ZUMZ) has an earnings quality ratio of 3.99x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Zumiez (ZUMZ) scores 40 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top